What We're Watching
China agrees to restrict fentanyl production
A bottle of fentanyl is displayed in Anyang city, central China's Henan province, 12 November 2018.
Reuters
China produces large quantities offentanyl, an opioid drug, much of which is then sold to drug cartels in Mexico that traffic narcotics into the United States. Fentanyl and other synthetic opioids were blamed for the overdose deaths of nearly 75,000 Americans in 2023.
For more than two years, the Biden administration has pressed China to stop the flow of chemicals used to make fentanyl. On Tuesday, China agreed to impose tougher restrictions and stricter oversight of the sale of three chemicals used to make fentanyl.
This tells us less about the future flow of opioids – they will probably continue to find their way across US borders – than about Beijing’s desire to protect stable and pragmatic relations with Washington. That is, at least until it becomes clear who will be inaugurated the next US president in January.
In his latest Quick Take, Ian Bremmer discusses the on-again off-again ceasefire between the United States and Iran and why it has failed to hold, arguing that both sides remain locked in a fundamental disagreement over who has the leverage.
Can a war-torn Lebanon disarm Hezbollah, end Israel’s occupation of its southern territory, and reclaim control of its future? Beirut-based journalist Kim Ghattas joins Ian Bremmer on GZERO World.
As Hezbollah’s power weakens and Israel occupies parts of southern Lebanon, could the country finally reclaim its sovereignty? Or is it headed toward another war? Journalist Kim Ghattas joins Ian Bremmer on the GZERO World Podcast.
Ian Bremmer breaks down how Iran spent four decades building Hezbollah into a powerful proxy against Israel, and why the group’s uncertain future could reshape the Middle East.